Tom Carroll is a Board Member and former Chief Operating Officer of Scene Health, formerly emocha, a mobile health company. He was responsible for leading the company’s expansion into new markets, and provided in-depth analyses on medication adherence-related cost savings and health outcomes improvements for Scene Health customers. Carroll is one of the most respected healthcare analysts in the industry with more than 25 years of experience in healthcare finance. Prior to Scene Health, he was the Managing Director at Stifel, where he produced equity research and analyst reports that were widely used by institutional investors and prominent media organizations. Carroll is the Co-Founder of RuxtonPark Healthcare Capital, and worked as a healthcare consultant at KPMG, Doctors Health Systems and Alexander & Alexander Consulting.
PUBLICATION & RECOGNITION
Carroll earned multiple research awards published by the Wall Street Journal, Starmine, Fortune Magazine and Forbes.
His esteemed research was used by newswires, institutional investors, and health-focused publications as well as CNBC, Bloomberg, and Fox Business.
Carroll was hailed by Fortune magazine as the No.1 U.S. healthcare analyst.
He has consistently placed in industry stock-picking awards, including top five finishes for stock picking from Starmine, The Wall Street Journal, and Forbes.